Concepedia

C. Lamot

CL

3

Publications

156

Citations

3

H-Index

2003

Active since

Affiliations

European Institute of Oncology(Current)

C. Lamot is an author at European Institute of Oncology specializing in gynecology oncology, obstetrics, and cancer therapeutics.

Top concepts

Publications per year

2003–2024

3

Publications

3

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 85 citations · Full text

, , +9

Outcome in a post-cardiac surgery population with acute renal failure requiring dialysis: does age make a difference?

Nele Van Den Noortgate, Veerle Mouton, C. Lamot et al. · Nephrology Dialysis Transplantation · 2003 · 59 citations · Full text

43O Durvalumab (D) + carboplatin/paclitaxel (CP) + bevacizumab (B) followed by D, B + olaparib (O) maintenance (mtx) for newly diagnosed advanced ovarian cancer (AOC) without a tumour BRCA1/BRCA2 mutation (non-tBRCAm): Updated results from DUO-O

Fabian Trillsch, Aikou Okamoto, JW Kim et al. · ESMO Open · 2024 · 12 citations · Full text

Rows per page

1–3 of 3